Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

NAUnknownINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

March 3, 2023

Study Completion Date

February 1, 2024

Conditions
Cardiogenic Shock
Interventions
PROCEDURE

Percutaneous coronary intervention (PCI)

Primary PCI or early/immediate PCI for NSTEMI will be undertaken according to recommended Guideline standards of care. This will include appropriate pre-loading with dual anti-platelet therapy, a preferred radial approach, intra-procedural anti-coagulation (with measure of ACT if considered appropriate every 30 minutes) and the use of drug eluting stents. Treatment will be delivered essentially to the culprit vessel only. A successful procedure will be one considered to have achieved TIMI 2-3 flow and residual stenosis \< 50%. PCI failure will not be an exclusion itself from the trial.

OTHER

Pharmacological Support

Use of pharmacological agents (Norepinephrine, Dobutamine, Levosimendan) according to ESC Guidelines to maintain mean arterial pressure \>75 mmHg in accordance with recognised standards of care. Changes in pharmacotherapy will NOT be regarded as escalation therapy. However the number of and dose of inotropes will be documented in the CRF.

DEVICE

VA-ECMO

"Following PCI of the culprit lesion, patients will have ECMO initiated as soon as echocardiography (to exclude mechanical causes) has been completed, once they have been assessed as having failed to improve (with the aim to start ECMO as early as possible from 30 mins after completed P-PCI procedure ad fully established within 6 hours after randomisation).~Peripheral Veno-arterial ECMO will be employed with a flow rate according to individual patient needs. Other methods of LV unloading, distal limb perfusion, maintenance of ejection/aortic valve opening and anti-coagulation will be instituted as per sites' usual care.~A minimum 24 hours be allocated to the randomised therapy in order that strategy failure is demonstrated but this will be at the physicians' discretion."

Trial Locations (47)

1002

RECRUITING

Paula Stradina Liniska Universitates Slimnica AS, Riga

1090

NOT_YET_RECRUITING

Medical University of Vienna, Vienna

2100

NOT_YET_RECRUITING

AZ Monica, Deurne

2300

NOT_YET_RECRUITING

AZ Turnhout, Turnhout

2610

NOT_YET_RECRUITING

University Hospital Antwerpen, Antwerp

NOT_YET_RECRUITING

ZNA Middelheim, Antwerp

2820

NOT_YET_RECRUITING

Imelda Hospital Bonheiden, Bonheiden

3000

RECRUITING

Katholieke Universiteit Leuven, Leuven

3500

NOT_YET_RECRUITING

Jessa Ziekenhuis Hasselt, Hasselt

8092

NOT_YET_RECRUITING

The Nordland Hospital, Bodø

8607

NOT_YET_RECRUITING

The Helgeland Hospital, Mo i Rana

9000

NOT_YET_RECRUITING

AZ Gent, Ghent

9019

RECRUITING

Universitetet i Tromsoe, Tromsø

9300

NOT_YET_RECRUITING

Algemeen Stedelijk Ziekenhuis Aalst, Aalst

NOT_YET_RECRUITING

Onze Lieve Vrouw Hospital Aalst, Aalst

9601

NOT_YET_RECRUITING

The Finnmark Hospital, Hammerfest

10154

NOT_YET_RECRUITING

Ospedale San Giovanni Bosco di Torino, Torino

23795

NOT_YET_RECRUITING

Segeberger Kliniken GmbH, Bad Segeberg

24127

NOT_YET_RECRUITING

Azienda Ospedalierea Papa Giovanni XXIII, Bergamo

35128

NOT_YET_RECRUITING

Università degli Studi di Padova, Padua

40138

NOT_YET_RECRUITING

University Hospital of Bologna Policlinico S. Orsola - Malpighi, Bologna

50134

NOT_YET_RECRUITING

Azienda Universitaria Ospedaliera Careggi, Firenze, Florence

72076

NOT_YET_RECRUITING

Uniklinikum Tübingen, Tübingen

78464

NOT_YET_RECRUITING

Herz-Zentrum Bodensee, Konstanz

79189

NOT_YET_RECRUITING

Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen

80336

RECRUITING

Klinikum Campus Innenstadt, München

80636

RECRUITING

Deutsches Herzzentrum München, München

80639

NOT_YET_RECRUITING

Barmherzige Brüder gemeinnützige Krankenhaus GmbH, München

81375

NOT_YET_RECRUITING

Klinik Augustinum, München

81675

NOT_YET_RECRUITING

Klinikum Rechts Der Isar, Munich

81377 Munich

RECRUITING

Ludwig-Maximilians-Universität München, München

08916

RECRUITING

Hospital Germans Trias I Pujol, Badalona

08035

RECRUITING

Hospital Vall d'Hebron, Barcelona

08036

RECRUITING

Consorci Institut D'Investicacions Biomediques August Pi i Sunyer / Hospital Clinic de Barcelona, Barcelona

08041

NOT_YET_RECRUITING

Hospital de Sant Pau, Barcelona

08907

RECRUITING

Hospital de Bellvitge, Barcelona

LE3 9QP

NOT_YET_RECRUITING

University Hospital Leicester, Leicester

ML6 0JS

NOT_YET_RECRUITING

Hairmyres Hospital, Airdrie

LE39QP

RECRUITING

University of Leicester, Leicester

NE2 4HH

NOT_YET_RECRUITING

Newcastle Freeman Hospital, Newcastle

G12 8QQ

NOT_YET_RECRUITING

University of Glasgow, Glasgow

CB23 3RE

NOT_YET_RECRUITING

Papworth Hospital, Cambridge

G81 4SA

NOT_YET_RECRUITING

Golden Jubilee National Hospital, Glasgow

EC1M 6BQ

NOT_YET_RECRUITING

St Barts and the London Hospital, London

SE1 2PR

RECRUITING

Kings College Hospital, London

SW3 6NP

RECRUITING

Harefield and Brompton London, London

Unknown

NOT_YET_RECRUITING

Guys and St Thomas NHS Foundation Trust, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

University of Glasgow

OTHER

collaborator

KU Leuven

OTHER

collaborator

University of East Anglia

OTHER

collaborator

Deutsches Herzzentrum Muenchen

OTHER

collaborator

A.O. Ospedale Papa Giovanni XXIII

OTHER

collaborator

Chalice Medical Ltd

UNKNOWN

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

University of Tromso

OTHER

collaborator

Institut d'Investigacions Biomèdiques August Pi i Sunyer

OTHER

collaborator

Paula Stradina Liniska Universitates

UNKNOWN

collaborator

Accelopment AG

OTHER

collaborator

Universiteit Antwerpen

OTHER

collaborator

European Cardiovascular Research Center

NETWORK

lead

University of Leicester

OTHER

NCT03813134 - Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock | Biotech Hunter | Biotech Hunter